1. Home /
  2. Pharmaceuticals


Tech Selloff Could Work in Favor of Pharmaceutical Stocks

Pharma could be the best parking spot for your money if the market keeps trending downward.

Pfizer Shares Rise Even as U.S. Lawmakers, Administration Criticize Drug Pricing

Shares of the New York City-based pharmaceutical giant are rising on Monday.

Pfizer's Oncology Offerings Present Opportunity for Long-Term Stock Growth

The cancer drug market is expected to grow from a surveyed total value of $78 billion in 2015 to over $110 billion by 2020.

Here's a Handful of Ways to Navigate Biotech's Choppy Seas

Biotech ETFs could mitigate risk amid the sector's volatility, and names such as Exelixis, ANI Pharmaceuticals and Progenics hold promise.

Pfizer Stock Slides Slightly as Drug-Maker Prepares Price Increases

Pfizer may have poked the bear.

Short-Sellers Stay Strong on Tilray Stock, Await January Judgment

Shorts aren't shying away from the cannabis industry even after a series of squeezes.

Eli Lilly Shares Decline on Tuesday Despite Strong Earnings Release

Eli Lilly's excellent earnings weren't excellent enough.

Wall Street Continues to See Opportunity in Eli Lilly

LLY's stock slide after earnings might present a buying opportunity.

Eli Lilly Offers Healthy Outlook to Kick Off November

The giant drugmaker raised its profit guidance for all of 2018 after its third-quarter results beat expectations.